Non-control transactions above the 20% limitThere are a number of exceptions to the restriction on acquisitions of shares above the 20% limit which do not require a takeover bid to be made to all shareholders. The main exceptions are described below.3.1 "Creeping" acquisitionsThe Corporations Act3 permits acquisitions of shares to be made above the 20% limit where the acquirer does not increase its voting power in the target company by more than three percentage points over a rolling six month period. The "creeping" acquisition exception allows shares to be acquired in any way, such as buying shares on market, participating in a new issue of shares, or entering into options or other arrangements with other shareholders.In order to rely on this exception, the acquirer must have held voting power in the target company of at least 19% throughout the six month period before the creeping acquisition.
- Forums
- ASX - By Stock
- Ann: December 2022 Quarter Production Update
GOR
gold road resources limited
Add to My Watchlist
0.30%
!
$3.27

Non-control transactions above the 20% limitThere are a number...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.27 |
Change
-0.010(0.30%) |
Mkt cap ! $3.552B |
Open | High | Low | Value | Volume |
$3.27 | $3.32 | $3.25 | $12.27M | 3.749M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 62067 | $3.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.28 | 51987 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 80 | 3.250 |
3 | 8708 | 3.240 |
1 | 3372 | 3.230 |
2 | 766 | 3.220 |
6 | 15000 | 3.200 |
Price($) | Vol. | No. |
---|---|---|
3.320 | 8500 | 1 |
3.330 | 300 | 1 |
3.340 | 36500 | 2 |
3.350 | 4960 | 2 |
3.360 | 20000 | 1 |
Last trade - 16.14pm 27/06/2025 (20 minute delay) ? |
Featured News
GOR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online